REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmasi Sri Nibong (Pekaka) Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Farmasi Sri Nibong (Pekaka) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farmasi Sri Nibong (Pekaka) Sdn. Bhd. is an enterprise in Malaysia, with the main office in Georgetown. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on February 07, 2007. Its’ total assets recorded a growth of 4.48%.

Legal Address
9-1, 9Th Floor, Wisma Penang Garden,, 42, Jalan Sultan Ahmad Shah,
Georgetown; Penang; Postal Code: 10050

Contact Details: Purchase the Farmasi Sri Nibong (Pekaka) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi Sri Nibong (Pekaka) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Farmasi Sri Nibong (Pekaka) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Sri Nibong (Pekaka) Sdn. Bhd. report to view the information.
Incorporation Date:
February 07, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Wellings Pg Sdn. Bhd.
23%
The Pill House Pharmacy Sdn. Bhd.
8%
Company Performance
Financial values in the chart are available after Farmasi Sri Nibong (Pekaka) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-99.56%
Net Profit (Loss) for the Period
-99.29%
Total assets
4.48%
Total equity
8.72%
Return on Equity (ROE)
-1225.38%
Quick Ratio
126.39%
Cash Ratio
103.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?